How do i transfuse platelets (PLTs) to reverse anti-PLT drug effect? (CME)

Transfusion

Volumn 52, Issue 4, 2012, Pages 695-701

  Sarode, Ravi ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; CALCIUM ION; CILOSTAZOL; CLOPIDOGREL; COLLAGEN; CYCLOOXYGENASE 1; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; DESMOPRESSIN; DIPYRIDAMOLE; EPTIFIBATIDE; FIBRINOGEN; FISH OIL; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHODIESTERASE; PRASUGREL; PROSTACYCLIN; PURINERGIC P2Y12 RECEPTOR; SEROTONIN; THROMBOXANE A2; THROMBOXANE SYNTHASE; TICLOPIDINE; TIROFIBAN; UNINDEXED DRUG; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING; DISEASE SEVERITY; DRUG BINDING; DRUG HALF LIFE; DRUG RESPONSE; GINKGO BILOBA; GINSENG; HUMAN; INTRAOPERATIVE PERIOD; LIFESPAN; PSEUDOTHROMBOCYTOPENIA; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE STRUCTURE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASOCONSTRICTION;

BLOOD PLATELETS; HUMANS; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET TRANSFUSION; PURINERGIC P2Y RECEPTOR ANTAGONISTS;

EID: 84859779025     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03282.x     Document Type: Article

References (28)

1. Bhatt DL,. Intensifying platelet inhibition-navigating between Scylla and Charybdis. N Engl J Med 2007; 357: 2078-81.
2. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R,. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998; 29: 1160-6.
3. Mayer SA,. Ultra-early hemostatic therapy for primary intracerebral hemorrhage: a review. Can J Neurol Sci 2005; 32 Suppl 2: S31-7.
4. de Gans K, de Haan RJ, Majoie CB, Koopman MM, Brand A, Dijkgraaf MG, Vermeulen M, Roos YB,. PATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial. BMC Neurol 2010; 10: 1-6.
5. Ivascu FA, Howells GA, Junn FS, Bair HA, Bendick PJ, Janczyk RJ,. Predictors of mortality in trauma patients with intracranial hemorrhage on preinjury aspirin or clopidogrel. J Trauma 2008; 65: 785-8.
6. Foerch C, Sitzer M, Steinmetz H, Neumann-Haefelin T,. Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage. Stroke 2006; 37: 2165-7.
7. Fortuna GR, Mueller EW, James LE, Shutter LA, Butler KL,. The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on outcomes in elderly patients with hemorrhagic brain injury. Surgery 2008; 144: 598-603; discussion -5.
8. Ott MM, Eriksson E, Vanderkolk W, Christianson D, Davis A, Scholten D,. Antiplatelet and anticoagulation therapies do not increase mortality in the absence of traumatic brain injury. J Trauma 2010; 68: 560-3.
9. Creutzfeldt CJ, Weinstein JR, Longstreth WT, Jr, Becker KJ, McPharlin TO, Tirschwell DL,. Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage. J Stroke Cerebrovasc Dis 2009; 18: 221-8.
10. Downey DM, Monson B, Butler KL, Fortuna GR, Jr, Saxe JM, Dolan JP, Markert RJ, McCarthy MC,. Does platelet administration affect mortality in elderly head-injured patients taking antiplatelet medications? Am Surg 2009; 75: 1100-3.
11. McMillian WD, Rogers FB,. Management of prehospital antiplatelet and anticoagulant therapy in traumatic head injury: a review. J Trauma 2009; 66: 942-50.
12. Seegmiller A, Sarode R,. Laboratory evaluation of platelet function. Hematol Oncol Clin North Am 2007; 21: 731-42, vii.
13. Shen YM, Frenkel EP,. Acquired platelet dysfunction. Hematol/Oncol Clin North Am 2007; 21: 647-61.
14. Patrono C, Baigent C, Hirsh J, Roth G,. Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 199S-233S.
15. Gawaz M,. Blood platelets: physiology, pathophysiology, membrane receptors, antiplatelets, and therapy for atherothrombotic diseases. New York: Thieme; 2001.
16. Borgdorff P, Handoko ML, Wong YY, Tangelder GJ,. COX-2 inhibition by use of rofecoxib or high dose aspirin enhances ADP-induced platelet aggregation in fresh blood. Open Cardiovasc Med J 2010; 4: 198-205.
17. Aster RH, Curtis BR, Bougie DW, Dunkley S, Greinacher A, Warkentin TE, Chong BH,. Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors. J Thromb Haemost 2006; 4: 678-9.
18. Said SM, Hahn J, Schleyer E, Muller M, Fiedler GM, Buerke M, Prondzinsky R,. Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment. Clin Res Cardiol 2007; 96: 61-9.
19. Dyszkiewicz-Korpanty A, Olteanu H, Frenkel EP, Sarode R,. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100). Platelets 2007; 18: 491-6.
20. Dyszkiewicz-Korpanty AM, Frenkel EP, Sarode R,. Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods. Clin Appl Thromb Hemost 2005; 11: 25-35.
21. Vilahur G, Choi BG, Zafar MU, Viles-Gonzalez JF, Vorchheimer DA, Fuster V, Badimon JJ,. Normalization of platelet reactivity in clopidogrel-treated subjects. J Thromb Haemost 2007; 5: 82-90.
22. Lecompte T, Hardy JF,. Antiplatelet agents and perioperative bleeding. Can J Anaesth 2006; 53: S103-12.
23. Bennett CL, Kim B, Zakarija A, Bandarenko N, Pandey DK, Buffie CG, McKoy JM, Tevar AD, Cursio JF, Yarnold PR, Kwaan HC, De Masi D, Sarode R, Raife TJ, Kiss JE, Raisch DW, Davidson C, Sadler JE, Ortel TL, Zheng XL, Kato S, Matsumoto M, Uemura M, Fujimura Y,. Two mechanistic pathways for thienopyridine- associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol 2007; 50: 1138-43.
24. Tsai HM, Rice L, Sarode R, Chow TW, Moake JL,. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura. Ann Intern Med 2000; 132: 794-9.
25. Khan NU, Wayne CK, Barker J, Strang T,. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph. Eur J Anaesthesiol 2010; 27: 624-7.
26. Flordal PA, Sahlin S,. Use of desmopressin to prevent bleeding complications in patients treated with aspirin. Br J Surg 1993; 80: 723-4.
27. Altman R, Scazziota A, DELH M, Gonzalez C,. Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation. J Thromb Haemost 2006; 4: 2022-7.
28. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T,. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352: 777-85.